CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex

참고문헌 (70)

1. Boyle, W. J., "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
2. Teitelbaum, S. L., "Genetic regulation of osteoclast development and function", Nat. Rev. Genet, 4, pp.638~649 (2003)
3. Väänänen, H. K., "The cell biology of osteoclast function", J. Cell Sci, 113, pp.377~381 (2000)
4. Roodman, G. D., "Regulation of osteoclast differentiation", Ann. NY Acad. Sci, 1068, pp.100~109 (2006)
5. Kikuta, J., "Osteoclast migration, differentiation and function : novel therapeutic targets for rheumatic diseases", Rheumatology, 52, pp.226~234 (2013)
6. Memczak, S., "Circular RNAs are a large class of animal RNAs with regulatory potency", Nature, 495, pp.333~338 (2013)
7. Qu, S., "Circular RNA : a new star of noncoding RNAs", Cancer Lett, 365, pp.141~148 (2015)
8. Ebbesen, K. K., "Insights into circular RNA biology", RNA Biol, 14, pp.1035~1045 (2017)
9. Zhai, Q., "CircRNA hsa_circ_0008500 acts as a miR-1301-3p sponge to promote osteoblast mineralization by upregulating PADI4", Front. Cell Dev. Biol, 8, pp.602731~ (2020)
10. Li, X., "Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7", GDF5, Stem Cell Res. Ther, pp.2018, 9[DOI]
11. Mi, B., "CircRNA AFF4 promotes osteoblast cells proliferation and inhibits apoptosis via the Mir-7223-5p", PIK3R1 axis, 2019, pp.11, 11988~12001
12. Jaiswal, N., "The role of skeletal muscle Akt in the regulation of muscle mass and glucose homeostasis", Mol. Metab, 28, pp.1~13 (2019)
13. Kawamura, N., "Akt1 in osteoblasts and osteoclasts controls bone remodeling", PLoS ONE, 2, pp.e1058~ (2007)
14. Sugatani, T., "Akt1", Akt2 and mammalian target of rapamycin, J. Biol. Chem, pp.2005, 280[DOI]
15. Lee, S. E., "The phosphatidylinositol 3-kinase, p38, and extracellular signalregulated kinase pathways are involved in osteoclast differentiation", Bone, 30, pp.71~77 (2002)
16. Moon, J. B., "Akt induces osteoclast differentiation through regulating the GSK3β", NFATc1 signaling cascade, 2012, pp.188, 163~169
17. Suzuki, E., "Akt activation is required for TGF-β1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts", PLoS ONE, 9, pp.e112566~ (2014)
18. Chen, K., "Sfrp4 repression of the Ror2", Jnk cascade in osteoclasts protects cortical bone from excessive endosteal resorption, 2019, pp.116, 14138~14143
19. Chen, K., "Boldine ameliorates estrogen deficiency-induced bone loss via inhibiting bone resorption", Front. Pharmacol, 9, pp.1046~ (2018)
20. Gao, Y., "CIRI : an efficient and unbiased algorithm for de novo circular RNA identification", Genome Biol, 16, pp.4~ (2015)
21. Langmead, B., "Fast gapped-read alignment with Bowtie 2", Nat. Methods, 9, pp.357~359 (2012)
22. Qiao, K., "LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p", MARK4, J. Exp. Clin. Cancer Res, pp.2019, 38[DOI]
23. Faulkner, K. G., "The tale of the T-score : review and perspective", Osteoporos. Int, 16, pp.347~352 (2005)
24. Bouxsein, M. L., "Guidelines for assessment of bone microstructure in rodents using micro-computed tomography", J. Bone Miner. Res, 25, pp.1468~1486 (2010)
25. Kiper, P. O. S., "Cortical-bone fragility-insights from sFRP4 deficiency in Pyle’s disease", N. Engl. J. Med, 374, pp.2553~2562 (2016)
26. Movérare-Skrtic, S., "Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures", Nat. Med, 20, pp.1279~1288 (2014)
27. Zhang, H., "CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα", ATM-p73 axis in bladder cancer, 2021, pp.20, 70~
28. Li, Q., "CircACC1 regulates assembly and activation of AMPK complex under metabolic stress", Cell Metab, 30, pp.157~173 (2019)
29. Chen, T., "The genome sequence archive family : toward explosive data growth and diverse data types", Genomics Proteomics Bioinformatics, 19, pp.578~583 (2021)
30. CNCB-NGDC Members and Partners, "Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022", Nucleic Acids Res, 50, pp.27~38 (2022)
31. Takahashi, N., "Generation of osteoclasts in vitro, and assay of osteoclast activity", Methods Mol. Med, 135, pp.285~301 (2007)
32. Miyamoto, T., "Differentiation and function of monocyte", macrophage lineage cells and osteoblasts, 2005, pp.63, 1511~1516
33. Glažar, P., "circBase : a database for circular RNAs", RNA, 20, pp.1666~1670 (2014)
34. Zeng, Z., "Circular RNA circMAP3K5 acts as a MicroRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation", Circulation, 143, pp.354~371 (2021)
35. Inada, M., "Animal models for bone and joint disease. Ovariectomized and orchidectomized animals", Clin. Calcium, 21, pp.164~170 (2011)
36. Jee, W. S., "Overview : animal models of osteopenia and osteoporosis", J. Musculoskelet. Neuronal Interact, 1, pp.193~207 (2001)
37. Huang, A., "Circular RNA-protein interactions : functions, mechanisms, and identification", Theranostics, 10, pp.3503~3517 (2020)
38. Kristensen, L. S., "The biogenesis, biology and characterization of circular RNAs", Nat. Rev. Genet, 20, pp.675~691 (2019)
39. Kim, M. J., "Hexosamine biosynthetic pathway-derived O-GlcNAcylation is critical for RANKL-mediated osteoclast differentiation", Int. J. Mol. Sci, 22, pp.8888~ (2021)
40. Li, J. H., "starBase v2.0: decoding miRNAceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data", Nucleic Acids Res, 42, pp.D92~D97 (2014)
41. Sato, S., "Modulation of Akt kinase activity by binding to Hsp90", Proc. Natl Acad. Sci. USA, 97, pp.10832~10837 (2000)
42. Zhang, R., "Hsp90-Akt phosphorylates ASK1 and inhibits ASK1-mediated apoptosis", Oncogene, 24, pp.3954~3963 (2005)
43. Yun, B. G., "Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation", Cell. Signal, 17, pp.1477~1485 (2005)
44. Redlak, M. J., "Targeting PI3K", Akt, Digest. Dis. Sci, pp.2011, 56[DOI]
45. Giustiniani, J., "Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt", PKB and p53, 2009, pp.21, 529~539
46. Haase, M., "HSP90AB1 : helping the good and the bad", Gene, 575, pp.171~186 (2016)
47. Parikh, C., "Disruption of PH-kinase domain interactions leads to oncogenic activation of AKT in human cancers", Proc. Natl Acad. Sci. USA, 109, pp.19368~19373 (2012)
48. Basso, A. D., "Akt forms an intracellular complex with heat shock protein 90(Hsp90)and Cdc37 and is destabilized by inhibitors of Hsp90 function", J. Biol. Chem, 277, pp.39858~39866 (2002)
49. Yang, Y. S., "Bone-targeting AAV-mediated gene silencing in osteoclasts for osteoporosis therapy", Mol. Ther. Methods Clin. Dev, 17, pp.922~935 (2020)
50. Yang, Y. S., "Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis", Nat Commun, 10, pp.2958~ (2019)
51. Zhou, W. Y., "Circular RNA : metabolism, functions and interactions with proteins", Mol. Cancer, 19, pp.172~ (2020)
52. Wilusz, J. E., "A 360° view of circular RNAs : from biogenesis to functions", Wiley Interdiscip. Rev. RNA, 9, pp.e1478~ (2018)
53. Wang, W., "Circ_0008542 in osteoblast exosomes promotes osteoclastinduced bone resorption through m6A methylation", Cell Death Dis, 12, pp.628~ (2021)
54. Gu, C., "CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma", Mol. Cancer, 20, pp.84~ (2021)
55. Zheng, Y., "The circular RNA landscape of periodontal ligament stem cells during osteogenesis", J. Periodontol, 88, pp.906~914 (2017)
56. Lin, J., "Circular RNA atlas in osteoclast differentiation with and without alendronate treatment", J. Orthop. Surg. Res, 15, pp.240~ (2020)
57. Gao, M., "The roles of circRNA-miRNA-mRNA networks in the development and treatment of osteoporosis", Front. Endocrinol, 13, pp.945310~ (2022)
58. Jiao, M., "Circular RNA and messenger RNA expression profile and competing endogenous RNA network in subchondral bone in osteonecrosis of the femoral head", DNA Cell Biol, 40, pp.61~69 (2021)
59. Zeng, Q., "The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey", J. Bone Miner. Res, 34, pp.1789~1797 (2019)
60. Söreskog, E., "Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older", Bone, 134, pp.115286~ (2020)
61. Clynes, M. A., "The epidemiology of osteoporosis", Br. Med. Bull, 133, pp.105~117 (2020)
62. Mafi Golchin, M., "Osteoporosis : a silent disease with complex genetic contribution", J. Genet. Genomics, 43, pp.49~61 (2016)
63. Rachner, T. D., "Osteoporosis: now and the future", Lancet, 377, pp.1276~1287 (2011)
64. Compston, J., "Practical guidance for the use of bisphosphonates in osteoporosis", Bone, 136, pp.115330~ (2020)
65. Khosla, S., "Osteoporosis treatment : recent developments and ongoing challenges", Lancet Diabetes Endocrinol, 5, pp.898~907 (2017)
66. Roberts, T. C., "Advances in oligonucleotide drug delivery", Nat. Rev. Drug Discov, 19, pp.673~694 (2020)
67. Crooke, S. T., "Antisense technology : an overview and prospectus", Nat. Rev. Drug Discov, 20, pp.427~453 (2021)
68. Nakamura, A., "Antisense oligonucleotide-based therapies for the treatment of osteoarthritis : opportunities and roadblocks", Bone, 138, pp.115461~ (2020)
69. Neckers, L., "Hsp90 inhibitors as novel cancer chemotherapeutic agents", Trends Mol. Med, 8, pp.S55~S61 (2002)
70. Wada, T., "RANKL-RANK signaling in osteoclastogenesis and bone disease", Trends Mol. Med, 12, pp.17~25 (2006)

관련 논문AI추천